What are the indications for Indometacine (indomethacin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Indomethacin

Indomethacin is FDA-approved for the treatment of moderate to severe rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis/tendinitis), and acute gouty arthritis. 1

Primary Indications

Acute Gout

  • First-line therapy for acute gouty arthritis at full anti-inflammatory doses 2
  • Recommended dosing: Full dosing at FDA-approved anti-inflammatory/analgesic doses 2
  • Typically administered until acute attack resolves 2
  • Particularly effective for pain relief in acute gout flares

Inflammatory Arthritides

  1. Rheumatoid Arthritis

    • Moderate to severe disease including acute flares of chronic disease 1
    • Suppresses inflammation as demonstrated by relief of pain, reduction of fever, swelling, and tenderness 1
    • May enable reduction of steroid dosage in patients receiving steroids for severe forms of rheumatoid arthritis 1
  2. Ankylosing Spondylitis

    • Moderate to severe disease 1
    • Used as a comparator drug in multiple clinical trials for AS 2
    • No evidence suggests indomethacin has different effects on pain or stiffness compared to other NSAIDs 2
  3. Osteoarthritis

    • Moderate to severe disease 1
    • Provides symptomatic relief but does not alter the progressive course of the underlying disease 1
  4. Acute Painful Shoulder

    • Effective for bursitis and/or tendinitis 1

Dosing Considerations

  • Use the lowest effective dose for the shortest duration consistent with treatment goals 1
  • For acute conditions: Full anti-inflammatory dosing (typically 50-150 mg daily) 3
  • Average daily dosage typically ranges from 75-100 mg for chronic conditions 3
  • Available in multiple formulations:
    • Standard capsules (rapid absorption)
    • Sustained-release formulations for once or twice daily dosing 4

Clinical Efficacy

  • Indomethacin is a potent inhibitor of prostaglandin synthesis 1
  • Long-term studies demonstrate good control of signs of active inflammation with daily indomethacin therapy 3
  • Provides improvement in functional capability as demonstrated by increased grip strength in rheumatoid arthritis 1
  • Improves mobility as demonstrated by decreased walking time in rheumatoid arthritis 1

Important Considerations and Precautions

  • Gastrointestinal Risk: Consider gastroprotection with a proton pump inhibitor, especially in high-risk patients 5
  • Cardiovascular Effects: May diminish cerebral blood flow; use with caution in patients with cardiovascular risk factors 1
  • Renal Function: Monitor renal function periodically, especially in at-risk patients 5
  • Elderly Patients: Higher risk of adverse effects; consider lower doses 5
  • Drug Interactions: Significant interactions possible; undergoes enterohepatic circulation 6

Alternative Options

When indomethacin is contraindicated or not tolerated:

  • Corticosteroids are generally safer and a low-cost treatment option for acute gout 2
  • Other NSAIDs (naproxen, ibuprofen) may be as effective with potentially fewer side effects 2
  • Colchicine is an alternative for acute gout when used at low doses 2

Long-term studies show that indomethacin can be well-tolerated when patients are carefully selected (those who do not experience initial side effects), with only 13% experiencing mild, transient side effects over periods ranging from 3-20 years of daily use 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical Pharmacokinetics of indomethacin.

Clinical pharmacokinetics, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.